Abstract
Aim:
To investigate the effects of Sonic hedgehog (shh) protein on bone marrow-derived endothelial progenitor cells (BM-EPC) proliferation, migration and vascular endothelial growth factor (VEGF) production, and the potential signaling pathways involved in these effects.
Methods:
Bone marrow-derived Flk-1+ cells were enriched using the MACS system from adult Kunming mice and then BM-EPC was cultured in gelatin-coated culture dishes. The effects of shh N-terminal peptide on BM-EPC proliferation were evaluated using the MTT colorimetric assay. Cell migration was assayed using a modified Boy den chamber technique. The production of VEGF was determined by ELISA and immunofluorescence analysis. The potential involvement of PKC and PI3K signaling pathways was explored using selective inhibitor or Western blot.
Results:
The proliferation, migration and VEGF production in BM-EPC could be promoted by endogenous shh N-terminal peptide at concentrations of 0.1 μg/mL to 10 μg/mL, and could be inhibited by anti-shh antibodies. Shh-mediated proliferation and migration in BM-EPC could be partly attenuated by anti-VEGF. Phospho-PI3-kinase expression in newly separated BM-EPC was low, and it increased significantly when exogenous shh N-terminal peptide was added, but could be attenuated by anti-human/mouse shh N-terminal peptide antibody. Moreover, the inhibitor of the PI3-kinase, but not the inhibitor of the PKC, significantly inhibited the shh-mediated proliferation, migration and VEGF production.
Conclusion:
Shh protein can stimulate bone marrow-derived BM-EPC proliferation, migration and VEGF production, which may promote neovascularization to ischemic tissues. This results also suggests that the PI3-kinase/Akt signaling pathways are involved in the angiogenic effects of shh.
Similar content being viewed by others
Article PDF
References
Asahara T, Kawamoto A . Endothelial progenitor cells for postnatal vasculogenesis. Am J Physiol Cell Physiol 2004; 287: C572–9.
Fan CI, Gao PJ, Che ZQ, Liu JJ, Wei J, Zhu DL . Therapeutic neovascularization by autologous transplantation with expanded endothelial progenitor cells from peripheral blood into ischemic hind limbs. Acta Pharmacol Sin 2005; 26: 1069–75.
Masuda H, Asahara T . Post-natal endothelial progenitor cells for neovascularization in tissue regeneration. Cardiovasc Res 2003; 58: 390–8.
Aicher A, Zeiher AM, Dimmeler S . Mobilizing endothelial progenitor cells. Hypertension 2005; 45: 321–5.
Ii M, Nishimura H, Iwakura A, Wecker A, Eaton E, Asahara T, et al. Endothelial progenitor cells are rapidly recruited to myocardium and mediate protective effect of ischemic preconditioning via “imported” nitric oxide synthase activity. Circulation 2005; 111: 1114–20.
Iwami Y, Masuda H, Asahara T . Endothelial progenitor cells: past, state of the art, and future. J Cell Mol Med 2004; 8: 488–97.
Dzau VJ, Gnecchi M, Pachori AS, Morello F, Melo LG . Therapeutic potential of endothelial progenitor cells in cardiovascular diseases. Hypertension 2005; 46: 7–18.
Hristov M, Weber C . Endothelial progenitor cells: characterization, pathophysiology, and possible clinical relevance. J Cell Mol Med 2004; 8: 498–508.
Kusano KF, Pola R, Murayama T, Curry C, Kawamoto A, Iwakura A, et al. Sonic hedgehog myocardial gene therapy: tissue repair through transient reconstitution of embryonic signaling. Nat Med 2005; 11: 1197–204.
Gianakopoulos PJ, Skerjanc IS . Hedgehog signaling induces cardiomyogenesis in P19 cells. J Biol Chem 2005; 280: 21022–8.
Pola R, Ling LE, Aprahamian TR, Barban E, Bosch-Marce M, Curry C, et al. Postnatal recapitulation of embryonic hedgehog pathway in response to skeletal muscle ischemia. Circulation 2003; 108: 479–85.
Sladowski D, Steer SJ, Clothier RH, Balls M . An improved MTT assay. J Immunol Methods 1993; 157: 203–7.
Fu JR, Liu WL, Zhou JF, Sun HY, Zheng M, Huang M . The effects of Mcl-1 gene in ATRA-resistant HL-60 cell. Chin J Heamatol 2005; 26: 352–4.
Lin P, Welch EJ, Gao XP, Malik AB, Ye RD . Lysophosphatidylcholine modulates neutrophil oxidant production through elevation of cyclic AMP. J Immunol 2005; 174: 2981–9.
Gehling UM, Ergun S, Schumacher U, Wagener C, Pantel K, Otte M, et al. In vitro differentiation of endothelial cells from AC133-positive progenitor cells. Blood 2000; 95: 3106–12.
Rafii S, Lyden D . Therapeutic stem and progenitor cell transplantation for organ vascularization and regeneration. Nat Med 2003; 9: 702–12.
Park C, Ma YD, Choi K . Evidence for the hemangioblast. Exp Hematol 2005; 33: 965–70.
Fu JR, Liu WL, Zhou YF, Zhou JF, Sun HY, Luo L, et al. Expansive effects of aorta-gonad-mesonephros (AGM)-derived stromal cells on HSCs from ESC. Chin Med J 2005; 118: 1979–86.
Nagase T, Nagase M, Yoshimura K, Fujita T, Koshima I . Angio-genesis within the developing mouse neural tube is dependent on Sonic hedgehog signaling: possible roles of motor neurons. Genes Cells 2005; 10: 595–604.
Miller LA, Wert SE, Clark JC, Xu Y, Perl AK, Whitsett JA . Role of Sonic hedgehog in patterning of tracheal-bronchial cartilage and the peripheral lung. Dev Dyn 2004; 231: 57–71.
Pola R, Ling LE, Silver M, Corbley MJ, Kearney M, Blake PR, et al. The morphogen Sonic hedgehog is an indirect angiogenic agent upregulating two families of angiogenic growth factors. Nat Med 2001; 7: 706–11.
Kliche S, Waltenberger J . VEGF receptor signaling and endothelial function. IUBMB Life 2001; 52: 61–6.
Asahara T, Takahashi T, Masuda H, Kalka C, Chen D, Iwaguro H, et al. VEGF contributes to postnatal neovascularization by mobilizing bone marrow-derived endothelial progenitor cells. EMBO J 1999; 18: 3964–72.
Palma V, Lim DA, Dahmane N, Sanchez P, Brionne TC, Herzberg CD, et al. Sonic hedgehog controls stem cell behavior in the postnatal and adult brain. Development 2005; 132: 335–44.
Kanda S, Mochizuki Y, Suematsu T, Miyata Y, Nomata K, Kanetake H . Sonic hedgehog induces capillary morphogenesis by endothelial cells through phosphoinositide 3-kinase. J Biol Chem 2003; 278: 8244–9.
Sasaki T, Irie-Sasak J, Jones RG, Stanford WL, Bolon B, Wakeham A, et al. Function of PI3Kγ in thymocyte development, T cell activation, and neutrophil migration. Science 2000; 287: 1040–6.
Author information
Authors and Affiliations
Corresponding author
Additional information
Project supported by the National Natural Science Foundation of China (No 30570773).
Rights and permissions
About this article
Cite this article
Fu, Jr., Liu, Wl., Zhou, Jf. et al. Sonic hedgehog protein promotes bone marrow-derived endothelial progenitor cell proliferation, migration and VEGF production via PI 3-kinase/ Akt signaling pathways. Acta Pharmacol Sin 27, 685–693 (2006). https://doi.org/10.1111/j.1745-7254.2006.00335.x
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1111/j.1745-7254.2006.00335.x
Keywords
This article is cited by
-
Therapeutic implication of Sonic Hedgehog as a potential modulator in ischemic injury
Pharmacological Reports (2023)
-
Switching of vascular cells towards atherogenesis, and other factors contributing to atherosclerosis: a systematic review
Thrombosis Journal (2020)
-
Sonic Hedgehog Promotes Cementoblastic Differentiation via Activating the BMP Pathways
Calcified Tissue International (2016)
-
The cholesterol biosynthesis enzyme oxidosqualene cyclase is a new target to impair tumour angiogenesis and metastasis dissemination
Scientific Reports (2015)
-
Overexpressing Sonic Hedgehog Peptide Restores Periosteal Bone Formation in a Murine Bone Allograft Transplantation Model
Molecular Therapy (2014)